CHA Vaccine Research Institute (KOSDAQ:261780)

KOSDAQ:261780 Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6,338	10,092	5,906	2,386	3,955	11,838
Short-Term Investments	24,550	22,550	32,990	55,377	47,500	3,000
Trading Asset Securities	505.49	7,465	-	-	10,095	9,989
Cash & Short-Term Investments	31,393	40,107	38,896	57,763	61,550	24,827
Cash Growth	-17.37%	3.11%	-32.66%	-6.15%	147.92%	179.65%
Accounts Receivable	0	-0	0	-0	-0	-0
Other Receivables	859.1	399.87	453.87	607.81	266.9	188.2
Receivables	859.1	399.87	453.87	607.8	266.9	188.2
Prepaid Expenses	88.6	106.63	94.23	117.1	12.94	8.52
Other Current Assets	4,813	3,977	3,042	429	17.07	13.91
Total Current Assets	37,154	44,590	42,486	58,917	61,847	25,037
Property, Plant & Equipment	937.82	1,120	1,644	1,543	1,032	586.81
Long-Term Investments	1,206	1,069	674.6	440	2,300	-
Other Intangible Assets	234.04	174.67	43.58	39.91	21.77	28.86
Long-Term Accounts Receivable	0	0	0	0	0	0
Other Long-Term Assets	284.39	294.39	270.9	129.08	112.5	94.43
Total Assets	39,816	47,248	45,119	61,069	65,313	25,747
Accrued Expenses	150.51	129.31	146.74	77.43	60.77	63
Short-Term Debt	11,198	4,950	-	23,240	20,717	-
Current Portion of Leases	6	8.35	162.92	381.21	112.8	101.77
Other Current Liabilities	9,068	4,526	500.53	3,090	3,816	4,641
Total Current Liabilities	20,423	9,613	810.18	26,789	24,706	4,806
Long-Term Debt	-	4,627	3,975	-	-	18,610
Long-Term Leases	-	3.81	188.65	16.53	16.14	128.94
Pension & Post-Retirement Benefits	1,743	1,620	1,203	882.35	737.9	443.16
Other Long-Term Liabilities	95.7	3,662	3,525	15.09	237.52	186.68
Total Liabilities	22,261	19,526	9,702	27,703	25,698	24,174
Common Stock	13,433	13,412	13,366	13,215	13,215	11,194
Additional Paid-In Capital	79,870	79,687	76,782	72,576	72,576	18,404
Retained Earnings	-76,230	-65,920	-55,457	-53,615	-46,921	-28,335
Comprehensive Income & Other	481.94	542.97	725.68	1,190	745.6	310.07
Shareholders' Equity	17,555	27,722	35,417	33,366	39,615	1,573
Total Liabilities & Equity	39,816	47,248	45,119	61,069	65,313	25,747
Total Debt	11,204	9,589	4,327	23,638	20,846	18,840
Net Cash (Debt)	20,189	30,518	34,569	34,125	40,704	5,986
Net Cash Growth	-29.23%	-11.72%	1.30%	-16.16%	579.94%	64.00%
Net Cash Per Share	752.72	1138.75	1304.13	1290.78	1745.71	333.84
Filing Date Shares Outstanding	26.83	26.82	26.73	26.43	26.43	17.93
Total Common Shares Outstanding	26.83	26.82	26.73	26.43	26.43	17.93
Working Capital	16,732	34,977	41,676	32,128	37,141	20,231
Book Value Per Share	654.31	1033.46	1324.89	1262.45	1498.91	87.72
Tangible Book Value	17,321	27,548	35,373	33,326	39,593	1,544
Tangible Book Value Per Share	645.58	1026.95	1323.26	1260.94	1498.09	86.11
Land	95.09	95.09	95.09	95.09	95.09	95.09
Buildings	402.68	402.68	402.68	402.68	402.68	402.68
Machinery	2,200	2,086	1,933	1,622	1,079	410.3

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.